Forbesindia - Dr. Alok Sharma

Leaders In
Healthcare
JUNE 2019
A special presentation complimentary with Forbes India. Not for Sale.

CONTENTS
5 Nat Health
6 Apollo Hospitals
8 Aster DM Healthcare
10 Dr. L H Hiranandani Hospital
12 Sir Ganga Ram Hospital
14 Manipal Education & Medical Group
16 Orchids Breast Health Centre
18 Neurogen Brain & Spine Institute
20 Jupiter Hospital
22 Becton Dickinson India Pvt Ltd
24 Bosch
26 Dr. PradeepV Mahajan (StemRx)
28 Care24
30 Suburban Diagnostics
ORIGIN MEDIA SOLUTIONS PVT LTD
105,‘B’Wing , Labh Ashish Building, Old Police Lane,
Andheri (East), Mumbai 400069
Manish Sharma – 9082746179
manish@originmediasolution.com
Sandeep Sharma – 7977059538
sandeep@originmediasolution.com
Marketing:
Shagufta Khan
Jitendra Gujar
Siddhi Patel
Advertising Sales:
Preeti Sahni
Mona Parate
Priyanka Nalavade
Janki Modi
Riti Menghani
Arijit Nandy
Daksha Solanky
Distribution:
Subhadra Bose
Kaushal Pillai
Advertising Operation:
Chaitali Karia
Smita Suvarna
Krishna Gupta
Prashant Rane
Forbes India Marquee, a marketing initiative, is a complimentary
supplement for Forbes India readers.
Design and Layout done by:
Disclaimer: This book is a special marketing initiative of Origin Media
Solutions in partnership with Forbes India Marquee. While Origin Media
Solution has taken utmost care to issue error free knowledge in the public
domain, readers are advised to independently verify the claims made in
the book. Origin Media Solution is not equipped to verify the claims made
in the book and readers discreet is therefore recommended.

4 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE
3,19,780 people, indicating bright career
opportunities. In fact, the contributions
of internationally credible education and
training centres and programmes such as
Hiranandani Orthopaedic Medical Education
and Manipal Education and Medical Group
are unparalleled.
This can be attributed to a number
of growth drivers such as infrastructural
investment, which, according to Invest
India, is expected to be $200 billion by 2024.
Improved life expectancy, as well as rising
disposable income and increased insurance
penetration, are other factors. Reduced
costs due to greater efficiency facilitated
by technology particularly robotic process
automation and rise in health and wellness
centres are also contributing to the growth
of India’s shining healthcare industry. Robotic
and computer assisted therapy is also used at
rehabilitationcentressuchasJupiterHospital’s
neuro-rehabilitation centre, which is also
home to Asia’s first aquatic rehabilitation pool.
With the government’s prerogative to roll-
out the world’s largest government-funded
healthcare programme, the importance of
providing quality, affordable and accessible
healthcare will continue to be the key
parameter for economic success.
In this supplement, we profile
changemakers and trendsetters in Indian
healthcare. They highlight the latest
advancements in the sector and the
challenges that lie ahead, as well as share
their road maps for a promising future.
India’s Dynamic Healthcare Sector
India has come a long way from the smallpox epidemic in 1974. Of course, there have been
newer challenges such as the swine u of 1 and the ipah virus outbrea in erala in 1
but that only proves how advanced our medical research is.
According to Invest India, the healthcare information technology market is expected
to grow 1.5 times from the current $1billion by 2020. Medical technology plays an
important role not just in terms of diagnostics and surgical procedures but also support
functions such as R&D and medical informatics.
Smart Healthcare
Telemedicine or telehealth is fast catching up. Video conferencing, for instance, saves time
and money. m-health (mobile health) and e-health are fast catching up too and there several
mobile applications for mental health, weight loss, chronic care management and more.
Applications that identify potential health threats and examine digital information also exist.
Telemonitoring technology has increased mobility, enabling doctors to monitor vital signs and
symptoms remotely.
In India, the home healthcare market size is roughly $4 billion with ancillary markets about
$20 billion. The concept of medical tourism is also flourishing and expected to grow to $9 billion
by 2020. Scientists have been able to examine diseases on a cellular level and produce antibodies
against them. Stem cell therapy has revolutionised the care of autistic patients, as well as those
suffering from strokes, spinal cord injuries, muscular dystrophy and cerebral palsy.
There are numerous surgeries which are being carried out without opening the body. Laser
operations, for instance. In fact, minimally-invasive surgeries such as transcatheter therapies are
allowing patients to spend less time in recovery.
The new technologies of today even allow doctors to find out an increasing amount
of detailed information about both, the progression and treatment of disease, and offer
personalised treatment based on a patient’s genes. The system of integrated patient clinics
has had a great impact where the patient meets with many specialists together. Before the
meeting, the doctors can access the patient’s detailed history.
A Promising Future
The value of India’s healthcare sector may increase to $372 billion by 2022 according to Invest
India. By 2020, India is expected to rank among the top three healthcare markets in terms of
incremental growth. In 2017, the industry stood as the fourth largest employer, employing
In India, the home
healthcare market size is
roughly $4 billion with
ancillary markets about
$20 billion. The concept
of medical tourism is also
flourishing and expected to
grow to $9 billion by 2020.
FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 5
NATHEALTH:
Powered By A
Critical Need
In celebration of our
7th anniversary, we
will recommit to our
vision in building a
better and healthier
India by unifying the
voice of the ecosystem
and harnessing its true
potential.
To solve this paradox is our most immediate
challenge. It will take our combined effort. It
will take our commitment and continuous
engagement. Most importantly, it will take a
spirit of collaboration and partnership from all
stakeholders.
Healthcare industry participants in India have
come together to work along with policy
makers to create an environment that will
power the next wave. NATHEALTH is the
genesis of this movement. It is the forum that
will facilitate the shift in mindset, delivery
and decision making. In celebration of our
7th anniversary, we will recommit to our
vision in building a better and healthier India
by unifying the voice of the ecosystem and
harnessing its true potential.
I
ndian healthcare is in a truly unique juncture at this point. At one end, we have taken giant
strides to establish ourselves as a highly skilled and efficient medical ecosystem with excellent
clinicaloutcomesdrivingapowerfulvalueproposition.Butthisiscounterbalancedbyamassive
disease burden, tangible dichotomies in healthcare delivery and massive infrastructure crunch.
is the genesis of a movement to bring the
healthcare ecosystem in one place. It is the forum that will
facilitate the shift in mindset, delivery and decision ma ing.
www. nathealthindia.org
Contact us at: secretariat@nathealth.co.in

6 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 7
Ms. Suneeta Reddy,
Managing Director,
Apollo Hospitals Enterprise Ltd.
Dr. Preetha Reddy,
Vice Chairperson,
6 FORBES INDIA MARQUEE . LEADERS
ratifies Apollo Hospitals’ position as the leader in Indian healthcare
industry.
Apollo Hospitals is today at the forefront of the Technological
Renaissance in healthcare. Leading from the front, Apollo Hospitals
has ensured that the best of medical advances and technology are
made available to the patients in India, making available world class
healthcare at a fraction of the cost as compared to other countries
across the globe.
Cardiovascular diseases and Cancer are the two main NCDs
responsible for premature mortality in India today, and along with
chronic respiratory disease and diabetes, the probability of dying
from these four NCDs is 26%! NCDs today account for 61% of total
deaths in India and with the vision and dedication to reduce these
numbers, Apollo Hospitals is the bulwark against the tsunami of Non-
communicable diseases (NCDs) that the country faces today.
Cardiovascular diseases including coronary heart disease, stroke,
and hypertension contribute to over 45% of all deaths from NCDs.
Heart problems can be diagnosed early, managed well and treated
completely in most cases and it is here that Apollo Hospitals has
redefined‘Heart Care’in the country.
Pioneering cardiac surgery with the repair of an Atrial Septal
defect in 1983, today, the Apollo Heart Institutes offer a multitude of
treatments and procedures in cardiology and cardiothoracic surgery
at centres across the country. Apollo Hospitals’ healing touch has
helped patients with an unmatched record of over 1,52,000 cardiac
and cardiothoracic surgeries, one of only 10 hospitals in the world to
achieve these volumes.
Apollo Hospitals’ journey in cardiac care has seen multiple firsts
including Coronary Artery Stenting for the first time in India, the first
keyhole multiple bypass surgery and the first heart transplant in India.
Today, Apollo Hospitals’ prowess in cardiac care is backed by the
largest cohort of cases treated with advanced cardiac interventional
methods. These include three key innovations – MitraClip, TAVI (Trans-
catheter AorticValve Implantation) orTAVR (Trans-catheter AorticValve
Replacement) and MICS CABG or MICAS (Minimally Invasive Coronary
Artery Bypass Surgery). Specialists in structural and interventional
cardiology at Apollo Hopsitals have successfully performed 6 MitraClip
procedures out of the 9 performed in India, over 85 TAVI/TAVRs with
Apollo Hospitals-
Bulwark Against
TheNCDTsunami!
The state-of-the-art Apollo Proton Cancer
Centre APCC in outh ast Asia rst of its
ind opened earlier this year, rati es Apollo
Hospitals’ position as the leader in Indian
healthcare industry.
A
renowned cardiologist known for his intuitive diagnostic
abilities, Dr. Prathap Reddy was just turning 50 when he
launched Apollo Hospitals and in the process revolutionised
healthcare in India. Thirty-six years later, with more than 32 million
people treated, the Apollo Hospitals group has become one of the
world’s leading centres for quaternary healthcare including cardiac
surgery, oncology, organ transplants (Heart, Lung, Liver, Pancreas,
Intestine and Kidney), bone marrow transplants, liver disease, joint
replacement and robotic surgery.
Today, Apollo Hospitals is renowned for delivering cutting-edge
healthcare embellished with a human touch at par with the best
centres in the world. The state-of-the-art Apollo Proton Cancer Centre
(APCC) in South East Asia – first of its kind – opened earlier this year,
excellent clinical outcomes and a nation-leading
1250+ MICS CABGs with superior outcomes at par
with international standards, at only half or one
third of the cost compared to global price matrix.
Cancer is the second leading cause of death
globally and according to the World health
Organization, 1 in 6 deaths globally in 2018 was
due to cancer. Apollo began its fight against cancer
in 1993 with a dedicated state-of-the-art facility for
cancer care in Chennai. Apollo has made significant
advances in treating this dreaded disease and has
been leading from the frontline in the war on cancer
by setting up South East Asia’s first proton therapy
centre for cancer, the Apollo Proton Cancer Centre
(APCC) launched earlier this year, which serves
over3.5 billion people across South East Asia. The
clinical advantages of proton therapy as compared
to conventional radiation therapy are many, with
more than 2,00,000 patients successfully treated
worldwide. Proton beam therapy takes the fight to
cancer with increased precision and greater dose
delivery at the precise site of the cancer, minimizing
damage to healthy tissue, better quality of life and
a higher cure rate. This ultimately results in better
results with fewer short and long-term side effects.
But even prior to the launch of the APCC, Apollo
Hospitals has always been quick to adopt new
technology to help advance treatment for cancer.
From the first Cyberknife Robotic Radio Surgery
SystemtotheTrueBeamSTxstereotaticradiosurgery
system, Apollo empowered its doctors to offer
patients with cancer, a non-invasive alternative
to traditional surgery. Cancer specialists at Apollo
Hospitals can use the most advanced TrueBeam
STx system, which is the fastest in treatment speed,
precision and simplicity to accurately target tumors
of the brain, spine, lung and other areas that are
typically difficult to treat surgically.
Apollo Cancer Institutes’ unique approach
to diagnosing, treating and monitoring cancer
powered by specialized expert organ-specific
tumor boards that discuss diagnostics and therapy
options to provide the most beneficial and effective treatment to thousands of patients.
As technology has evolved rapidly over the last two decades, Apollo Hospitals has
also been at the forefront in adopting Artificial Intelligence (AI) to bring a paradigm shift
to the practice of medicine with tools designed to equip doctors in the fight against
the rising burden of NCDs, especially cardiology, cancer and neurology. Apollo Hospitals’
Intelligent Platform – designed in collaboration with Microsoft – helps to predict
cardiovascular disease risk score in the Indian population. Doctors across the Apollo
network of hospitals are today leveraging this AI-powered API to predict risk of CVD and
drive preventive cardiac care across the country.
Combining Applied AI and clinical expertise, many other platforms are being
developed for other NCDs that include Adult diabetes care pathway, Hypertension
treatment and control pathway, cholesterol management in cardiovascular risk pathway,
and prevention of stroke and CVA. The future will see AI playing a major part at Apollo
Hospitals in prediction and monitoring of disease while empowering physicians with the
power of data to make superior clinical decisions.
Dr. Prathap C. Reddy
Founder, Chairman Apollo Hospital Group
Ms. Sangita Reddy,
Joint Managing Director,
Ms. Shobana Kamineni,
Executive Vice Chairperson,

DM Healthcare’s India operations are often
leveraged for their expertise in advanced
tertiary and quaternary care, and each year
its multi-specialty hospitals in Kerala and
Bengaluru receive a significant number of
patients from international markets.
In India, Aster DM Healthcare is also being
recognised for clinical excellence and the
introduction of innovative medical solutions
that address patients’ needs. Recently, at
Aster CMI Hospital in Bengaluru, a 13-year
old patient from Mauritius was brought,
suffering from rarest of the rare Complement
Deficiency genetic disease, C1q deficiency
since the age of 2. She underwent a
successful bone marrow transplant for the
condition and became the first teen in Asia
suffering from this complex condition to
receive this particular treatment. Globally, less
than 10 such cases have been successfully
transplanted.
Aster Medcity Hospital is another example of
the company’s high quality and personalised
medical care commitment. A 670-bed
multi-specialty quaternary care facility with
10 dedicated Centres of Excellence, it is
the first quaternary care hospital in Kerala
to have achieved the coveted JCI (Joint
Commission International) Accreditation –
the gold standard in global healthcare and is
considered a focal destination for healthcare
tourism from across the world. Aster MIMS
Hospital in Calicut was declared a Centre for
Quality Promotion (CQP) by the Consortium
of Accredited Healthcare Organisations
and is known for performing successful
advanced medical procedures like renal
transplants using robotic surgical systems
Quality Healthcare
made affordable and
accessible in India
As one of the top healthcare service providers in India,
Aster DM Healthcare continues to push the boundaries
of healthcare excellence.
T
he healthcare market is India is expected to reach US$ 372 billion by 2022, while the
hospitals industry is expected to grow at a CAGR of 16-17% to reach Rs. 8.66 trillion by
FY22. This growth will be primarily driven by rising incomes, better health awareness,
growing incidence of lifestyle diseases and improving access to health insurance. With the
government’s prerogative to roll-out the world’s largest government-funded healthcare
programme, the importance of providing quality healthcare that is affordable and accessible
will continue to be the key parameter for economic success.
At Aster DM Healthcare, the universal healthcare philosophy of Quality, Affordability and
Accessibility for all was ingrained in the company, since its inception in 1987 in the UAE. Starting
from a single clinic in Bur Dubai, to becoming a globally integrated healthcare conglomerate
with 24 hospitals, 114 clinics and 219 pharmacies across nine countries, Aster DM Healthcare
has over the last 15 years grown from strength to strength providing quality care through
its network of 12 hospitals and eight clinics in India. Today, it is the third largest healthcare
provider in India by market capex.
The company commenced its India operations in 2001 with the establishment of the Malabar
Institute of Medical Science in Calicut (Aster MIMS), Kerala, which offers end-to-end care
across primary, secondary, tertiary and quaternary healthcare. Within its global network, Aster
and transcatheter aortic valve implantations
(TAVI), which have set the benchmark for
clinical excellence in the region. Aster MIMS
Hospital in Kottakal, DM WIMS in Wayanand
and the recently introduced 300 bedded
Aster MIMS Hospital in Kannur are some of
the other facilities in Kerala. Apart from Kerala,
Aster Hospitals are located in 4 others states in
India: Aster CMI Hospital in Bengaluru (Aster
RV Hospital to be operational soon); Aster
Aadhar Hospital in Kolhapur, Maharashtra;
Aster Prime Hospital in Telengana; and
Ramesh Hospitals in Andhra Pradesh.
As part of its commitment to India, Aster DM
Healthcare listed its stocks on the Bombay
Stock Exchange in February 2018. A significant
proportion of the proceeds gathered from
the IPO are now being used to strengthen its
offerings in India. In addition, the company is
constantly striving to enhance the learning
opportunities for its doctors. Aster has been
recognised by the Royal College of Obstetrics
and Gynaecologists (RCOG) for its international
programme accreditation for Core Medical
Training (CMT). Aster Medcity in Kerala and
Aster Hospital at Mankhool in Dubai UAE will
be the second in the world after Iceland to
deliver CMT outside the UK. Aster Medcity has
also signed an MOU with theThomas Jefferson
University, USA to provide its doctors with
access to global knowledge, research and best
practices. The first collaboration to be initiated
is a multi-organ transplant programme.
As one of the top healthcare service providers
in India, Aster DM Healthcare continues to
push the boundaries of healthcare excellence
and provide compassionate care to people
across geographies.
Q&A with Dr. Azad Moopen-
Founder Chairman and Managing
Director, Aster DM Healthcare
A single clinic in 1987, to a chain
of hospitals present in multiple
countries. Please share your inspiring
entrepreneurial journey till now.
When we started Aster DM Healthcare as
a single doctor clinic in Dubai in 1987, we
wanted to provide affordable quality healthcare
services to people. Over the last three decades,
our efforts have seen us expanding our offering
beyond Dubai, to other GCC countries and
India. We operate now in 9 countries with 24
hospitals, 114 Clinics and 219 Pharmacies.
We commenced our India operations in 2001 with the establishment of the Malabar
Institute of Medical Science (Aster MIMS) in Calicut, Kerala and currently we have 12
hospitals and 8 clinics in India with a total bed capacity of 4400. We see India as a growth
market and with this thought we listed our company in India in February 2018.
Aster DM Healthcare recently completed a year of listing in India. How has the
one year journey been? Also, what is your strategy and focus for Indian market?
We see India as a growth market. With 12 hospitals in India, we are now looking at
expanding our presence through organic growth and acquisitions. We would like to
further consolidate our presence in South and Western India. Our model is to have large
hospitals with 300-500 beds in major cities. If any opportunity comes up in the North
which is suited to our business model, then we can consider.We prefer asset-light model
where the land and building are either on long-term lease hold or O&M.We can also look
for inorganic growth through acquisitions if the valuations are reasonable.
Presently, 17% of our revenues come from India and our aim is to increase the figure to
25% revenue from India in the next few years. Considering the current demand for quality
healthcare, India is a focus market for us where we have 4,400 beds and have plans to take
it up to 6,000 beds through 3 hospitals which are in the pipeline: Bengaluru, Chennai and
Thiruvananthapuram. For this, we have plans to invest upto Rs750 crore by 2022.
You aim to be a global health service provider. What differentiates you from
other healthcare service providers?
We are different from other healthcare service providers as we provide complete
specialties of services from primary to quaternary care through the network of clinics,
hospitals and pharmacies. We do everything from primary consultation to cardiology
transplantations in our hospitals. Another differentiating feature is that we have 3
separate brands in GCC catering to the upper, middle and lower-income groups called
Medcare, Aster and Access. At some point of time in future we would like to expand it to
other countries including India.
Another very important point which differentiates us from other healthcare providers is
our major involvement in academics with an intake of nearly 1000 students every year
which helps us to have a pipeline of medical professionals. One of the most important
differential features is Aster Volunteers which is the CSR arm of Aster providing service to
large number of people every year in India. We believe that God has given us health and
wealth, part of which has to be given back free of cost to needy people.
Dr. Azad Moopen
Founder Chairman and Managing Director,
Aster DM Healthcare

not get into the syndrome of Chronic Heart
Failure that may leave them without many
options or commonly unaffordable treatment
options. Fame spread, the US FDA chose us
as the only hospital in Asia to be part of US
FDA global study for the Robotic arm to be
used in Angioplasty. Today the department
is recognized as a centre of excellence. The
hospital was the first in the country to utilize
the Bio absorbable stent. The department
handles complicated procedures as total
chronic occlusion (CTO). Our Cardiologist
is invited internationally to showcase these
acquired skills. This unit is now proctoring
offshore Cardiologists. Reversal of dominance
and a red letter day for the hospital, city and
India!! Today we are proud to state that we
are one of the 4 hospitals to be associated
with the American Heart Association to be
in a collaborative study for the treatment of
hypertension in Asians.
Hiranandani Orthopaedic Medical
Education
The hospital marched ahead in the field
of Orthopaedics. We were the pioneers in
computer navigation surgery in the city.
We devised protocols for patient safety that
have gained International recognition and is
published in leading Orthopaedic Journals.
This has resulted in a dramatic decrease in
post-operative complications. Also using
the computer navigation in most cases has
given fine results as cases performed in 2004
are being followed up in the hospital and
they are without any symptom. This is an
outstanding achievement as the incidence
of revision surgery increases after the first
decade. The department went into using
platelet rich plasma for chronic ligament
and joint paint with outstanding results.
Many a sportsperson has benefitted from
this therapy. Our Postgraduate teaching
program was developed under Hiranandani
Orthopaedic Medical Education (HOME).
Our work has gained us recognition as
being an Orthopaedic training centre by
SICOT (Societe Internationaale de Chirurgie
Orthopedique et de Traumatologie or the
International Society of Orthopaedic Surgery
and Traumatology). Many a young orthopod
has crossed these portals. The department
has evolved into a comprehensive centre that
Dr L H Hiranandani Hospital
Laboratory The National
Accreditation For All Its Services
FROM GETTINGTHE ISO CERTIFICATION IN 2006THE
HOSPITALTOOKTHE GIANT STEP IN 2007TO GETTHE NABH
ACCREDITATION FROMTHE QUALITY COUNCIL OF INDIA.
I
naugurated on the 22nd of February, 2004, the Dr L H Hiranandani Hospital is located
in the picturesque Hiranandani Gardens at Powai. Armed with the mission of ‘Being
the preferred choice for healing and good health’, the hospital set about its task of
engaging in rendering quality of care. And with very good reason, the hospital aspired to
mirror the long and illustrious career of a titan in the field of medicine in general and ENT
in particular – Padmabhushan Dr L H Hiranandani.
From getting the ISO certification in 2006 the hospital took the giant step in 2007 to get
the NABH accreditation from the Quality Council of India. This was a first not only in the
city of Mumbai but also in the Western region of India!!Thus not a single act of our hospital
coming into being remained mundane. The hospital marched on to get its Laboratory the
National accreditation for all its services (NABL) in 2008 and then marched on to even have
the Blood Bank get the NABH accreditation in 2011. The hospital has aspired for excellent
Nursing and this led us to also the Nurses to be recognized by the Quality Council with
Nursing Excellence in March 2016. We thus gave meaning to standardization in healthcare
as the hospital has refined process that are followed.
While quality has been the cornerstone of this dynamic outfit, professionally too we were
well recognized. Arguably ours was the first hospital to popularize and propagate Primary
Angioplasty in Myocardial Infarction (PAMI) and we not only saved lives but have also
ensured those afflicted do not have myocardial damage! This certainly means that they will
renders all forms of orthopaedic treatment, from joint replacement,
spine surgery, orthopaedic surgery, sports injury therapy and all this
encompassed with a sound physical rehabilitation centre that can
take care of each need right from removing pain to restoring strength.
Department of Obstetrics and Gynecology
The greatest joy that a family experiences is to welcome a new member
in its midst. Thus delivering the happiness quotient has been the ‘True
North’for the Department of Obstetrics and Gynecology. Not only was
the department able to deliver this happiness, but soon turned into
a centre of excellence that could offer treatment for the woman from
‘womb to tomb’. Today the department has a diversified into many
specialized clinics. They are – Pre pregnancy counseling, Infertility (Male
and Female) or Human reproduction – The department also leads in
all techniques related to human reproduction with benchmarked
results. The equipment to deliver this sort of excellence is sourced from
leading vendors and with the expertise existing the results had to be
extraordinary. Surgical excellence has been the core competence in
the department. Today we perform the true‘Stitch less’vaginal surgery
for operations that are generally performed by the abdominal route.
Minimal access surgery is performed using all the available techniques
in the world. Pregnancy may be complicated and to address such
conditions we have the ‘High Risk Pregnancy’ Clinic. We also have
fetal medicine experts who have the skill to accurately diagnose fetal
abnormalities in early pregnancy that can be followed up and therapy
decided at birth or even early intervention when the baby is still in the
mother’s uterus. There are doctors who have a program for women’s
cancer risk prevention.Then again the menopausal clinic for the seniors
to live a life where they are active and can sustain on their own.
Process are validated for effectiveness and revalidated if any new
modality is introduced for better patient outcome. The hospital thus
has incorporated the clinical pathways for better patient outcome,
reduced hospital stay and also very minimal use of antibiotics. This
reduces the overall cost to the patient. Clinical pathways have also
ensured a degree of safety for patients. Early destarvation has resulted
in lesser use of antiemetic and also intravenous fluids.
The introduction of the system of integrated patient clinics has had a
great impact on patients. The coordinator in the department arranges
a meeting of the patient with a number of specialists together. Before
meeting the patient the doctors have already gone through the
detailed history and when they meet with the patient they are in a
position to tailor make a treatment plan for that one person.This make
the patient singularly well informed and at the same time they feel
involved with their own treatment as they now feel that they are also
an integral part of the team that is planning the therapy. This is a huge
confidence building measure for the patient. The hospital has over
50 service streams to render treatment. Those that have performed
remarkably well are Ophthalmology, Metabolic medicine including
Bariatric Surgery, Foot care and management, High Risk OPD for
Paediatric Evaluation and so on. The hospital has a social side too that
looks after the physically and mentally challenged.
The hospital was confident that it was on the track that Chairman
Hiranandani would have wanted. Thus to determine how good that
quality was, we competed at the Ramkrishna Bajaj National Quality
Award (RBNQ) for the first time in the year 2008 and were declared
winners pan India. The next year, 2009, we went on to compete at
the International Asia Pacific Quality Award and were also the winners
there. This possibly for the first time a hospital from India had bagged
this prestigious award. There were other accolades that followed. The
hospital again marched ahead to be the winner of the RBNQ for the
year 2015. In a span of 12 years we have imprinted the stamp of quality
in healthcare across the country.
Even before the inaugural stone was laid on the foundations of Dr
L H Hiranandani Hospital, in the first flush of the new millennium,
everyone associated with it could see that it was a more sublime affair
than mere brick and mortar. And with very good reason. When a yet-
to-be-born hospital, -however swanky, however massive, - aspires to
mirror the long and illustrious career of a titan in the field, the usual
concerns of hospital management and business blue-printing are the
first to go out of the window.
One chooses the nobler and brighter options over practical and gainful
ones, choices that are worthy of the name it is founded on. And when it
is a tribute to an iconic father by his almost equally accomplished sons,
it even transcends the question of honour. It becomes an act of love.
Today we are proud to state that we are
one of the 4 hospitals to be associated with
the American Heart Association to be in
a collaborative study for the treatment of
hypertension in Asians.
Super ICU:
Such like work would not have been possible
with a strong Intensive Care Unit back up.
The hospital has the concept of a‘Super ICU’.
The unit is capable of monitoring any and
every parameter required to treat a seriously
ill patient. The unit follows the best air-
conditioning standards. This is benchmarked
against stringent standards. There are special
units to treat the patient with very serious
infection called the negative pressure room
and the positive pressure room for the
patient who has little resistance to infection.
This unit is monitored by a large team of
full time Intensive care experts.
Dr L H Hiranandani Hospital

of the society. Sir Ganga Ram Hospital’s
doctors contribute to the hospital out of their
professional earnings, which is ploughed back
to maintain the growth and flagship of the
hospital. Due to this unique cooperative stake
holding of this hospital, the hospital is rightly
called“People’s Own Hospital”.
Service Excellence :
Talent, Infrastructure
The Board of Management is very particular
and fair in selecting intelligent, passionate
and compassionate doctors at the time of
induction and provides them an ambient
culture to further their skillsets and academic
growth. Every consultant is required to devote
adequate time for teaching and research. Sir
Ganga Ram Hospital is well sought by young
consultants and eminent doctors all across
India.Wefeelproudthatsomanyofourdoctors
who joined as young consultants have attained
national and international eminence in their
fields. Upcoming hospitals look up to Sir Ganga
Ram Hospital faculty for guidance and cutting-
edge approach. We are proud of our role as a
‘Nursery’ that stresses on training healthcare
professionals devoted to the society. To guard
against any malpractices, we have instituted a
strong medical ethical committee.
Patient Comfort
Hospital is continuously making efforts to
improve patient comfort and convenience.
Following steps have been taken:
OPD areas have been renovated with
adequate waiting space
Smart OPD concept to enable booking, Q
Managementandhasslefreeconsultations
Multi Level Car Parking commissioned in
2018 to facilitate parking of over 1000 cars
Future Plan: A new block with additional
beds and ultra modern Cancer Centre is
under construction and a separate OPD
block is also under construction
S
ir Ganga Ram, an excellent civil engineer, great philanthropist and founder of Sir
Ganga Ram Trust Society established the first hospital in 1921 at Lahore, which is still
known as Sir Ganga Ram Hospital. In 1954, the Trust Society established a 50 - bed Sir
Ganga Ram Hospital at New Delhi. The Trust Society, in 1976 handed over the management
to the Board of Management, which comprised of eminent consultants from the hospital
itself. Through these turn of events, the Board of Management with its dynamic and visionary
leadership and guidance, and harmonious relationship with the Trust Society, directed the
hospital to reach its present eminence. At present, the 675-bedded tertiary care hospital
is equally known for quality and ethical healthcare and excellence in the field of medical
education and research. Sir Ganga Ram Hospital is now a role model for the National Board
of Examinations and provides postgraduate courses in 42 disciplines.
Making a difference to all sections of Society
A dedicated and eminent faculty is our core strength. The Trust Society members render selfless
service and are committed to above-par and ethical healthcare, which is equipped with the
latest technology and provided to all sections of the society. The hospital runs free OPDs in the
morning in all specialities, which includes free consultations, highly subsidized investigations,
free drugs and free investigations to EWS category patients. In addition to that, the hospital
runs free emergency services round the clock and 20% of the indoor beds are reserved for free
medical care. Beds that are charged are divided into three categories as per different sections
GRIPMER : Innovation, Academics, Research
We strongly believe that medical education and research are essential
components in delivering quality and updated medical care. In order
to consolidate and further strengthen our academic and research
activities we established Ganga Ram Institute of Postgraduate Medical
Education & Research (GRIPMER) in the year 2012. GRIPMER has
signed agreements with various governmental & non-governmental
organizations of India as well neighbouring countries to promote
research and capacity building in training medical professionals. Sir
Ganga Ram Hospital is a pioneer in establishing an excellent Medical
Genetics department that offers a Ph.D. program.
We have got several research projects being funded by important
national organizations like ICMR, DST, Department of Biotechnology
etc. and significant international organizations like UNICEF, WHO and
others.The hospital is recognized as a Scientific and Industrial Research
Organisation (SIRO) by the Department of Scientific & Industrial
Research since 2000. Sir Ganga Ram Trust Society is committed to
reach rural population at their doorsteps through our charity outreach
program and telemedicine, which has best consultants on board.
Brand Committment
Sir Ganga Ram Hospital is firmly committed towards providing
excellent healthcare with passion and compassion while strictly
adhering to medical ethics. The hospital is devoted to impart
postgraduate medical education to doctors, producing dedicated
nurses and running structured para-medical courses to provide
competent medical professionals to the country. The hospital is
involved in meaningful clinical and molecular research and extends its
support to various government and non-government organizations
in promoting health and prevention of diseases. There are efforts to
promote alternative systems of medicine, too when clinically proven.
Message from the Chairman, Board of Management
Serving this great institution for the last 38 years and being one of
the pioneers in establishing comprehensive nephrology, dialysis and
kidney transplantation services in the non-government sector, I feel
privileged to give back to the institution by serving Chairman of Board
of Management since 2011.
The hospital is
recognized as a Scientific
and Industrial Research
Organisation (SIRO)
by the Department of
Scientific & Industrial
Research since 2000.
CORE VALUES
Sir Ganga Ram Hospital is a patient-friendly
hospital with a“Patient First Policy”. It is
committed to holistic healthcare, cutting-
edge research and a training ground
for competent healthcare professionals.
State-of the-art technology has been the
hospital’s key strength. We have been
the first in acquiring latest technologies
over last four decades. It is a doctor
and an employee-friendly hospital.The
management is transparent and open-
minded. Both service providers and service
takers have a sense of belonging
and are partners in the
growth of the hospital.
I believe that all tertiary care hospitals should endeavor to provide
quality and affordable healthcare at the doorsteps of rural India. The
Government should give land on lease to genuine NGOs and further
infrastructural support should come by India Inc as part of their CSR
activities. Tertiary care hospitals should further provide expertise of
their talented doctors and help in capacity building of these centres
to eventually make them self-sustainable.
The Medical Council of India should regulate the quality of medical
education and pay the pedagogy adequately. Besides, controlling the
price of life-saving drugs and promotion of generic drugs, the Drug
Controller should ensure quality.
Sir Ganga Ram Hospital Marg, Rajinder Nagar, New Delhi - 110060,
24 Hour Helpline : 25750000, 42254000, Fax: +91-11-25861002,
E-mail: gangaram@sgrh.com Visit us at www.sgrh.com
People’s Own
Hospital
Sir Ganga Ram Hospital is now a role model for the National
Board of Examinations and provides postgraduate courses
in 42 disciplines.
Dr. D.S. RANA, MBBS, MD, MNAMS, FISN, DSc, FGSI
Awarded Padma Shri by the Hon'ble President of India
Dr. B.C. Roy National Awardee
Chairman, Board of Management
Chairman, Department of Nephrology
Trustee, Sir Ganga Ram Trust Society

Ballal, the Chairman of Manipal Health
Enterprises, adds, “At MEMG, the technology
initiatives provide the freedom to deliver new
pedagogic methods and systems of learning.”
Each of the skills imparted are extremely
relevant and welcomed in the corporate
sector, the advantage of wearing two hats -
the teacher and the business leader.
That said, Pai’s healthcare business is
also providing to be a sweet spot with
investors. Recently, Singapore’s state-owned
investment company Temasek Holdings
bought out private equity investor True
North’s entire 18% stake in the hospital chain
for `1,100 crore, valuing the Company at an
estimated $1 billion. Already an established
hospital network in South India, it was
inevitable that Manipal Health would eye
a pan-India expansion at some point. Dr
Ranjan Pai wants to entrench the Manipal
brand in healthcare, not just in India but also
in other countries. The Company already has
a network of 10 hospitals across India, with
4 hospitals managed and, additionally, has
one in Malaysia, and a clinic in Nigeria—
with close to 6,500 beds, of which the city
of Bengaluru alone has 1,100 beds. Manipal
Health has now forayed into the north and
has a 300-bed multi-specialty hospital in
Jaipur, Rajasthan, and one in Dwarka, New
Delhi, with 450 beds.
Manipal Health has also built its business
around the tertiary-care model and is not
dependent on one particular specialization.
“We have centers of excellence and some
of the best doctors in the country - who are
leaders in their fields, extremely competent
support staff that delivers on global
standards, and skillful med-support.” added
Dr. Ballal. The culture of social sustainability is
driving excellence in the healthcare brands.
The brand’s vision to provide affordable
healthcare comes from a deeply insightful
space. With a view to contribute a solution
to the inaccessibility of affordable healthcare
across the country, Manipal Health has
partnered with the Government of India’s
initiative - Ayushman Bharat, a health
insurance cover of ` 5 lakhs per family, for 50
crore beneficiaries from below poverty levels,
constituting around 40% of the population,
forsecondaryandtertiarycarehospitalization.
also incubates start-ups affiliated to these
sectors.
However, the basic premise of all the
companies and institutions under the MEMG
umbrella stays the same today - a charter that
requires them to offer socially relevant and
affordable services. But this was the basic
premise of Dr. TMA Pai’s vision, all along - his
firm belief that if every person of our country
has access to good education and healthcare,
the person will have a good livelihood and
be a productive citizen. Interestingly, in the
1990s United Nations, defined the eco-socio
development status of a country through
a “human development index”, where two
of the three components of the index were
the education level and health status of its
people – a fact Dr. Pai recognized over half a
century ago.
The focus of MEMG is to contribute towards
creating human skill pools in the country
to support economic development by
setting up educational institutions. This
creation of skill pools has extended to other
countries too, especially in Malaysia and
Nepal. Over the years, Manipal graduates
in clinical, engineering, management and
other academic disciplines have contributed
significantly to the economic and industry
development in regions across India and in
countries overseas.
MEMG, today, is one of the foremost umbrella
institutions in India. It combines world
class skills development with sustainable
enterprise - and under the guidance of Dr.
Ranjan Pai, leverages technology to move
ahead with futuristic visions. Dr. H Sudarshan
The Manipal Experience
H
e might be a doctor by training but he’s better known as an astute investor and a
successful entrepreneur. Defying conventional wisdom that says doctors can’t be
good businessmen, some people have the ability to work for the society and also raise
successful, sprawling business enterprises. One of whom is the Bengaluru-based billionaire
entrepreneur Dr. Ranjan Pai who heads an Education and Healthcare empire in India.
The Pai family has been operating in the field of education for three generations as the Manipal
Education and Medical Group (MEMG). Padmashri Dr. Tonse Madhava Ananth Pai, Ranjan’s
grandfather, set up India’s first private, self-financed medical college in 1953, in Manipal, in
the State of Karnataka. Over the years more colleges were set up in various disciplines and
in 1993 this institution was given a university status and became the Manipal Academy of
Higher Education (MAHE), which, recently, has been recognized by the Government of India as
an “Institution of Eminence. The educational institutions grew in leaps and bounds under the
leadership of Ranjan’s father, Padma Bhushan Dr Ramdas M Pai, who expanded the footprint
beyond Karnataka to set up universities and educational institutions in Sikkim and overseas in
Malaysia, Nepal, Dubai and Antigua.
Continuing with the strong legacy, Ranjan professionalized the operations and established
ManipalEducationandMedicalGroupasacorporateenterprise.Movingonfromjusteducation,
MEMG’s offerings, today, are broadly spread across four key verticals of Education, Healthcare,
Research and Foundation. A recent investment entry is in the health insurance sector. MEMG
At MEMG, the
technology initiatives
provide the freedom to
deliver new pedagogic
methods and systems
of learning.
Dr. Ranjan Pai
Group Chairman, Manipal Education and Medical
Delivering Excellence in
Healthcare and Education:
Says Dilip Jose, MD & CEO of Manipal Health Enterprises,“With plans to provide the best in class
primary, secondary and tertiary healthcare, we think that Ayushman Bharat is very relevant
initiative for our country. With 15 hospitals, including our teaching hospitals, and over 6000
beds, we can extend our support to geographies that are underserved in healthcare. While the
basic building blocks for affordable healthcare are in place, what is needed is a progressive and
proactive approach, backed by innovation, to healthcare delivery.”
Over the last few years, Dr Ranjan Pai has gained the reputation of being a patient investor who
has built a very focused yet diverse portfolio. His willingness to channel funds into startups that
focus on high-risk sectors such as life sciences and biotechnology where investor interest is
usually low—has won him the admiration of peers and entrepreneurs.
Leveraging technologies like artificial intelligence (AI), blockchain, and data analytics to provide
this support, is another of Dr. Pai’s vision for MEMG. Generating and using data to improve health
outcomes, maintain electronic health records and cloud storage and even consumer-facing
mobile apps, empower patients as well as healthcare providers to deliver much better service.
As Dr. Ballal, says,“We at Manipal Health are committed to providing a patient centric, clinically
excellent and an ethical-technology driven health care. We are also looking at a viable PPP
model to drive the exciting, yet challenging, universal health care mission of the Government’s
Ayushman Bharat, the largest of such initiatives in the world.”
Padmashri Dr. Tonse Madhava Ananth Pai, Ranjan’s
grandfather, set up India’s rst private, self- nanced medical
college in 19 , in Manipal, in the State of arnata a.
Dr. H Sudarshan Ballal
Chairman, Manipal Health Enterprises
Dilip Jose
MD & CEO, Manipal Health Enterprises
“We at Manipal Health are
committed to providing a
patient centric, clinically
excellent and an ethical-
technology driven health
care. We are also looking at
a viable PPP model to drive
the exciting, yet challenging,
universal health care mission of
the Government’s Ayushman
Bharat, the largest of such
initiatives in the world.”
“With plans to provide
the best in class primary,
secondary and tertiary
healthcare, we think that
Ayushman Bharat is very
relevant initiative for our
country. With 15 hospitals,
including our teaching
hospitals, and over 6000 beds,
we can extend our support
to geographies that are
underserved in healthcare".

around mid-forties. Lack of awareness about disease symptoms,
early diagnosis contribute to late diagnosis, delayed treatment and
high mortality. Unnecessary Mastectomy (i.e, total breast removal) is
common practice which scares women from receiving appropriate
institutional treatment. Therefore, considering the growing BC burden
in India, OBHC has developed multi-pronged, high-impact, innovative
initiatives in the fight against BC.
International Standards in BC Clinical Management
1) Advanced Breast Cancer Diagnostics
OBHC is equipped with sophisticated imaging modalities such as
Contrast Enhanced Digital Mammography with 3D Tomosynthesis
(first in India) and Automated Breast Volume Scanner. Precision biopsy
procedures with Vacuum-assisted Biopsy and Robotic arm-guided
Stereotactic biopsy are available at affordable rates.
2) Pioneering Breast Oncoplastic Surgery in India
BOS is a new paradigm that combines principles of BC surgery and
cosmetic surgery in the same sitting.Loss of breast via mutilating
surgeries can lead to psychological trauma and depression, thereby,
decreasing survival rates. BOS allows for tumor removal, breast
shape and size restoration and good cosmesis in a single surgery.
BOSpositively impactspatient psyche, self-esteem and body image
resulting is better quality of life.
Under the leadership of Dr. Koppiker, an international renowned
surgeon and it’s Medical Director, OBHC has pioneered BOS in India. At
OBHC, about 75% patients undergo breast saving BOS procedures. In
20%ofcasesthatabsolutelyrequiremastectomy,breastreconstruction
is performed in the same sitting in majority of cases. The rates of
total mastectomy are as low as 4%, perhaps, one of the lowest in the
world.In the past 5 years, OBHC team has performed over 1500 BOS
procedures with various innovative techniques.
Training
With an objective of reducing mastectomy rates in India by creating
a well-trained BOS work-force, OBHC and senior surgeons from the
University of East Anglia (UEA), UK have conducted hands-on training
workshops. Dr. Koppiker has been conferred with a faculty position
in the University of East Anglia, UK and the American School of
Oncoplastic Surgery.
In 2017, OBHC and UEA have jointly started an academic degree
program (M.Ch. in Breast Oncoplasty) which is the only course in
Asia offering cutting-edge BOS training (www.breastoncoplasty.
org). Over 50 surgeons from India and South East Asia (Sri Lanka,
India's State-Of-
The-Art Breast
Cancer Centre
O
rchids Breast Health Center (OBHC), an initiative of the Prashanti
Cancer Care Mission (PCCM) Pune , is a one-of-its-kind ‘Centre
of Affordable Excellence in Breast Care in India’. OBHC has
pioneered several innovative techniques in breast diagnostics and
surgery – ONCOPLASTIC BREAST SURGERY. It is a unique research-
driven enterprisecomprising of a team of onco-clinicians, radiologists,
geneticists, clinical scientists, physicians, psycho-oncology counselors
and dieticians at its core. OBHC has blended state-of-the-art clinical
managementstrategieswithcommunityoutreach,trainingandresearch.
OBHC Initiatives for Fight against Breast Cancer (BC)
in India
According to WHO, breast cancer is now the most common cancer
in India affecting all socio-economic strata of the society (1, 62,468
new BC cases diagnosed annually) with highest global mortality rate.
Majority of BCs in India are detected in young, premenopausal women
Indonesia, Maldives, Afghanistan, Bangladesh) have enrolled full-time
in the program while over 500 surgeons have been trained in various
workshops conducted all over India.
Translational Breast Cancer Research
Indian BC cancer profile is different than other countries with reference
to its epidemiology, clinico-pathology as well as clinical management.
Unlike the west, majority Indian BC cases are diagnosed in advanced
stage and predominantly in young, premenopausal women. Triple
negative breast cancer (TNBC) is an aggressive and difficult-to-treat
disease highly prevalent in Indian women. Hence, it is incorrect to
directly extrapolate research findings from western population in
treating Indian BC patients.
All leading international cancer hospitals (i.e., M.D. Anderson
Cancer Centre, Houston, USA, Institute of Cancer Research, London)
have established highly successful cancer research programs. On
similar themes, PCCM has joined hands with Indian Institute of
Science Education and Research (IISER), a premier national research
institute in Pune in 2017 to establish a Centre of Translational Cancer
Research (CTCR), supported by seed fund from Bajaj Auto Ltd. CTCR
has undertaken major BC themed-research relevant to Indian context
in the themes of public health, epidemiology, genetics, OBS, chemo-
radiation and psycho-oncology.
CTCRresearchagendaincludesunderstandingthemolecularbasis
of high prevalence of TNBCs in India population.Fruitful collaborations
with world-renowned breast cancer clinicians and researchers from
USA and UK have been established. UniqueTNBC genetic patterns and
molecular biomarkers have been identified that will be helpful to the
Indian onco-clinicians in better prevention, diagnosis and treatment.
CTCR has also undertaken major initiatives in capacity building of
cancer researchers by conducting novel training programs in research
methodology, molecular oncology, bioinformatics, preclinical and
clinical research. In September 2019, CTCR will be hosting the first-
ever conference in Indian based on‘The Cancer Genome Atlas ( TCGA)
which is world’s largest open-source database for cancer research
funded by National Cancer Institute , USA.
Community Outreach
1. Sensitization
Based on WHO guidelines, OBHC conducts BC awareness campaigns
in Pune that sensitizes thousands of women in Pune annually.
ImportantBC-related information is provided in all languages to dispel
myths about the signs, symptoms, diagnosis and treatment aspects
with an emphasis on quality of life. In addition, regular symposia are
organized for the community to discuss breast cancer related issues
with experts. OBHC also organizes one of Pune’s largest breast cancer
awareness marathon (‘Our Marathon’) with over 15,000 participants.
2. Screening
OBHC has created aClinical Breast Examination (CBE)-based screening
program in which women are examined by breast palpation
performed by well-trained para-medicals and medical social workers.
A mobile mammography project was created to screen women
(above 40 years) for breast abnormalities in which trained radiologists
examined the mammograms.In2016-17 over 50,000 women were
sensitized via awareness talks and 6500 women were screening
using CBE and mammography. The diagnosed cases identified via
this screening program were treated free of cost at OBHC.
3. Chemotherapy Corpus
With the help of generous donors, OBHC has also created a
chemotherapy corpus to provide free and concessional life-saving anti-
cancer drugs, including Herceptineto underprivileged patients (1238
concessional and 539 freeships amounting to over 2 Cr in FY 2018-19)
4. Patient Support
Rehabilitation is the most important arm of breast cancer requiring
significant support from family and friends, OBHC has created a
PINK -RIBBON support group which provides support to patients
and caregivers via organizing transport, babysitting, nutritional
programs,psychological counseling, picnics and get togethers.
These initiativesare spearheaded by Ms.LalehBusheri,(CEO, PCCM)
and members of the support group. The aforementioned high-
impact projects of PCCM and CTCR will receive a significant boost
with generous support from socially-conscious organizations and
individuals. Therefore, it is our earnest appeal to corporate houses,
high-net worth individuals, philanthropists and NGOs to join hands
with PCCM in the fight against breast cancer in India by supporting
the ongoing and future activities; with the credo “Losing is Not an
Option - Be it Hope, Breast or Life”.
OBHC ACHIEVEMENTS
Global recognition as pioneers in Breast Oncoplastic
Surgery (BOS) in India
Largest number of BOS cases (over 1500 oncoplastic
and reconstructive procedures)
Pan-Asia training BOS training program
State-of-the art advanced breast cancer radio-
diagnostics and precision biopsies
Translational cancer research in collaboration with
reputed national and international partners
Innovative social-impact, community programs in
breast cancer awareness and prevention
Dr. C B Koppiker
Training surgeons at LA
A one-of-its-kind centre that has pioneered
several innovative techniques in breast
diagnostics and surgery.
Training Workshop with UK Faculty
Laleh Busheri
CEO, Prashanti Cancer Care Mission
(PCCM)

18 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 1918 FORBES INDIA MARQUEE . LEADERS
autism has been published by NeuroGen Brain & Spine Institute, in the
prestigious journal Stem Cell International.
In adults, Stem cell therapy performed at NeuroGen brings
about inspiring improvements in the paralytic symptoms of patients
with spinal cord injury, brain stroke and head injury. In deteriorating
conditions, like motor neuron disease, muscular dystrophy and other
neurodegenerative disorders, it offers lifesaving, stabilizing treatments
and improves the quality of life of patients, infusing vitality in their day-
to-day lives. Since its inception in 2008, NeuroGen has successfully
treated over 8000 patients from over 65 countries. We have been
accredited by ISO 9001-2015 and have a GLP (Good Laboratory Practice)
and GMP (Good Manufacturing Practice) certified stem cell laboratory.
Mission & Vision
To make a difference to the lives of patients suffering from
incurable/intractable diseases and injury of the nervous system,
by providing them with the most effective and safest available
treatments & technologies from the field of neurosciences and
regenerative medicine
To offer return of function, relief from symptoms and recovery from
illness in a professional, holistic and caring manner in a world-class
institution
To conduct basic & clinical research and to constantly work on
innovation & development so that the best therapeutic strategies
can be evolved
Our People
A medical team (Neurosurgeon, Neurophysician, Pediatrician,
General Physician and Anesthetist)
A basic science team (Neuropathologist and Regenerative
Medicine Scientist)
Arehabilitationteam(Physiotherapist,Occupationaltherapist,Clinical
Psychologist, ABA Therapist, Pediatric Physio Therapist, Speech
Therapist, Aquatic therapist, Special Educator and Nutritionist)
OUR RESEARCH
At NeuroGen, there is a strong emphasis on honest, diligent academic
work and rigorous clinical research, along with patient treatment. A
detailed and unbiased analysis of the clinical data is carried out and
published in various scientific journals on a regular basis, so that there
is transparency about our work. Currently, 86 scientific papers have
been published by our team in various international and national peer-
reviewed medical journals. We also have 7 chapters in International
textbooks, in addition to 16 published books.
AWARDS RECEIVED:
NeuroGen has achieved awards in various National and
International forums, as below:
National Awards
“The Best Stem CellTherapy centre in India”by National Healthcare
Excellence award in 2016 at New Delhi, India.
“The Best Stem Cell Therapy center in Maharashtra”by Navbharat
Healthcare Excellence award, June 2017 at Mumbai, India.
“Best Super Specialty Hospital” of the year January 2017, at New
Delhi, India.
Dr. Alok Sharma:
Brings Extensive
Surgical Expertise In The
Areas Of Neurosurgery
N
euroGen Brain & Spine Institute, Navi Mumbai, India is
an international center of excellence for neurological
disorders. Founded on 17th December 2008 by a renowned
Neurosurgeon, Neuroscientist and Professor Dr. Alok Sharma,
it has been set up specifically to treat incurable neurological
conditions, through a combination of stem cell transplantation and
comprehensive neurorehabilitation.
Dr.Sharmabringswithhimextensivesurgicalexpertise&experience
in the areas of Neurosurgery, Neuroscience and Regenerative Medicine.
A trailblazer in the field of Stem cell therapy for neurological disorders,
he has over 25 years of experience in the field of Neurosurgery and has
several awards and recognitions to his name. He has authored 16 books
and has over 150 scientific papers published in various medical journals.
NeuroGen has played a pivotal role in developing revolutionary
treatmentforchildrenwithAutism,CerebralPalsy,IntellectualDisability
and other neurological disorders. The knock-on consequences of
our therapy result in improvements of their cognitive abilities and
helps them to seamlessly integrate back into mainstream society.
The world’s first scientific publication on the role of cell therapy in
“Quality Heath Services in Neuro Sciences” by International
Excellence Awards, March 2017, at Goa, India.
“International Excellence Award for Service to Disabilities” by
Hon’ble Minister of Government of India Minister of Social Justice
and Empowerment, Delhi (August 2017)
“Emerging Stem Cell & Neurology Centre in the year (India)” by
Brands Academy Award in December 2016 at New Delhi, India.
“Excellence in Stem Cell Therapy in Maharashtra” by India Today
Excellence Health Care Award at Mumbai (June 2018)
“Best Stem Cell Research Hospital in India” at the hands of
Dr. Anupriya Patel, Hon'ble Minister of State in the Ministry of
Healthcare & FamilyWelfare, Government of India (Nov. 2018)
International Awards
“The Rose of Paracelsus Award, by EMA (Oxford UK)” at Cannes,
France, October 2016.
“European Awards for Best Practices 2018” by European Society
of Quality Research at Brussels, Belgium, May 2018.
“Inspirational Company” by World Confederation of Business at
St. Thomas, Virgin Islands, USA, July 2017.
“Best Hospital” Europe business assembly (EBA) at Dubai,
January 2017.
What is Stem Cell therapy and how does it help
patients with incurable neurological disorders?
Stem cells are specialized cells that can potentially convert into any type
of tissue under specific physiological conditions, and have the ability
to repair damaged parts of our body. Stem cell therapy is a simple and
effective treatment and is 100% safe when autologous adult stem cells
are used. Statistics have shown that, after Stem cell therapy, overall
90% of patients with Autism have shown improvements in social
relationships, emotional responses, speech, communication, behavior
and hyperactivity. 77% of Stroke patients showed improved upper and
lower limb activity, 96% of patients with Spinal Cord Injury showed
better muscle tone, trunk activity, balance and other activities of daily
living. In Cerebral Palsy, 91% of treated patients showed improvement
in oromotor/speech functions, balance, and upper/lower limb activity.
In Muscular Dystrophy, which is a progressive disease of the muscles,
about 86% of the patients attain stabilization of their condition, along
with improved functionality.
Dr.Alok Sharma (M.S, M.Ch.)
Director – NeuroGen Brain & Spine Institute,
Navi Mumbai
Over 2 years of experience in the eld of
Neurosurgery and has several awards and
recognitions to his name.
FACILITIES PROVIDED:
Eleven floors, 75 bedded hospital with all the Medical and
Surgical facilities with state-of-the-art Stem Cell Laboratory
All the Neurorehabilitation Dedicated departments for various
therapies such as Physiotherapy, Occupational Therapy, Neuro-
psychologicalintervention,Speechtherapy,Neurodevelopmental
therapy and Diet Counselling
Dedicated Autism Child Development Centre that involves
complete assessment and evaluation of the child, Neuroimaging
tests and all kind of therapies like Applied Behavior Analysis
(ABA), Occupational Therapy, Psychological Intervention, Special
Education, Speech Therapy, Dance Therapy, Art Therapy, Play
Therapy, Music Therapy, Physiotherapy, Group Therapy, Animal
Therapy, Family Counseling, Pharmacotherapy (Medications).
One-of-a-kind facilities in the country, including a Spinal Cord
Injury Walking Track, which empowers wheelchair bound spinal
cord injury patients to come back on their feet, as well as Aquatic
Therapy to enable patients to freely perform movements that are
difficult to perform on land.
CORPORATE SOCIAL RESPONSIBILITY:
As an institute, we understand that coping with a neurological
disability is as traumatic to the patient’s family as it is to the patient.
Hence, we aim to extend our support in every possible way, not just
before or during the treatment, but also beyond. As its corporate
social responsibility, NeuroGen Brain and Spine Institute has
been helping out patients financially from lower socio-economic
background as well.
We at NeuroGen always strive to make our patients independent and
spread smiles, by bringing a paradigm shift in the treatment methods
employed for patients with intractable neurological disorders. Our
future is full of hope, with plans to expand our work by establishing
multiple centers of excellence worldwide.We wholeheartedly believe
in formulating superlative therapeutic strategies for our patients, that
extend their functional abilities to the maximum possible extent and
restore their faith in the beauty of life.
NeuroGen Brain & Spine Institute
Sector 40, Plot No 19, Near Seawoods Grand Central Station,
Off Palm Beach Road, Nerul (W), Navi Mumbai -400706.
Mob: 9920200400, Tel:022-41136565,
Email: contact@neurogenbsi.com, Web: www.neurogenbsi.com

Jupiter’s approach of ‘Patient First’ has inspired them to bring the
best aspects of modern medicine along with state-of-the-art
infrastructure under a single multi-functional premise, right from
day one. With the belief that patient-centric care is much more
than just clinical skills and medical care, the hospital focuses
on providing cutting-edge technologies and state-of-the-art
infrastructure to provide comprehensive and advanced care to
patients as well as their families.
With a vision to provide the country with a convenient one stop
access to multi-therapy services that cater to the rehabilitation
needs of the patient, a comprehensive neuro rehab department
has been set up in Jupiter Hospital Thane, Mumbai. The Jupiter
Neuro Rehab Centre provides interdisciplinary rehabilitation and
is one of the finest in world, with the latest robotic and assisted
devices for inpatients as well as its outpatient rehab patients. A key
feature of the centre is the ability to manage complex disabling
conditions with robotic, computer assisted rehabilitation & aquatic
rehabilitation. Neuro rehab provides specialized management for
people who have physical and/or cognitive impairments as a result
of brain or spinal cord injury, stroke, cerebral palsy, Parkinson’s
disease or other progressive and non-progressive neurological
condition. It includes musculoskeletal conditions as well.
The centre also offers a unique Aquatic Rehabilitation Program
which comprises of Asia first aquatic gym which is a temperature
controlled pool, with 5 gym equipment with graded resistance
inside the water. This aquatic gym utilizes the unique properties of
warmwatertopromotefasterrecoveryforpatientswithStroke,Brain
injuries, Spinal cord injuries, physical weakness/deconditioning,
fibromyalgia, low back and neck pain, sports related injuries,
arthritis, orthopedic injuries/surgeries. Supported by the buoyancy
of warm water, patients are able to perform therapies that increase
Jupiter Hospital:
Paralysis Rehab
The most advanced neuro-rehabilitation
center in Jupiter Hospital comprises of
unconventional robotic and computer-assisted
therapy and also houses Asia’s rst aquatic
rehabilitation pool.
E
stablished in 2007, Jupiter Hospital has been operating as one
of the finest built multispecialty hospitals with well-planned
infrastructure and facilities in the city of Thane in Maharashtra,
India. The 375+ bedded, NABH and NABL accredited tertiary care
hospital, has been successful in catering to the rising healthcare needs
of the growing population of Thane and beyond. Recently recognized
as the Hospital of theYear in Healthcare Asia Awards 2019, the hospital
caters to all branches of medicine right from maternity and newborn
care up to geriatrics and palliative care. Jupiter’s second hospital in
Pune was established in 2016 and is the region’s finest integrated
healthcare facilities with world-class infrastructure, latest technologies
and skilled doctors.
strength and muscle tone, range of motion
and mobility; all while decreasing pain
and improving overall well-being. Specific
aquatic exercises for strengthening, balance,
coordination, spasticity & deep stabilization
are also an essential part of aquatic rehab.
“Rehab is an important part of a patient’s
journey to complete recovery”, says
Dr. Amit Ramesh Dhumale, Director of
Neuro-rehabilitation at Jupiter hospital.
"A well-planned rehabilitation program
plays a crucial role in helping a patient learn
to work around the challenges and live an
independent life. With the state-of-the-art
rehab centre, we have taken a positive step
A well-planned
rehabilitation program
plays a crucial role in
helping a patient learn
to work around the
challenges and live an
independent life. With
the state-of-the-art rehab
centre, we have taken
a positive step towards
providing something very
unique to India.
towards providing something very unique to India. While our department has a 200 sq ft
exclusive gym area, what is more important is that we have the comprehensive skill sets and
the best of equipment that provides conventional therapy as well as a whole set of computer-
aided and robotic rehabilitation devices. Each of these device has been selected after a
thorough study of what would be beneficial to a patient in the Indian scenario. And it is a
matter of pride for Jupiter, that the we are able to offer technology and care that is superior
than some of the most advanced cities in USA”.
Highlighting the need for such inter-disciplinary neuro rehabilitation in the country, he says,
“A coordinated, structured and integrated rehabilitation program helps restore a patient’s
physical & cognitive function in the best way, thereby enabling him to lead a normal life. It
is the need of the hour to have such setups in India, and we believe that more such setups
should be established all across the country. In the US for instance, there are around more 500
well-equipped state-of-the-art rehab centres, while in India we have only 4-5 rehab centres
that are well-equipped and in the position to treat patients with such problems”.
In addition to out-patient & day care programs, the centre is supported by five dedicated
inpatient beds (special rooms) with a first-of-its-kind system of lift hoists for each bed that will
get the patient from the bed to the centre. The centre – with its state-of-the art facilities and a
well-trained team - aims to provide convenient, individualized, safe, timely, compassionate &
highest quality of rehabilitation care to patients.

lab or a nurse handling hazardous drugs or a physician prescribing
medication—from anesthesia delivery to syringes and needles.
Trusted partnerships have provided impetus to this journey of
redefining medication management technologies to support health
systems in making their processes safer, smarter, and simpler.
In 2019, BD Global Health signed a MoU with USAID/India to
collaborate on a strategic partnership to advance GoI’s aim to
improve health outcomes by strengthening health systems in the
key priority areas of Tuberculosis, Antimicrobial Resistance, HIV/
AIDS, Family Planning and Maternal & Child Health.
Labs for Life (L4L) is a global, multi-country partnership between
CDC and BD; helmed by NACO in India and implemented by
CMAI. It aims to strengthen laboratory systems by enhancing
testing capacity, improving quality of services, strengthening
sample referral mechanisms, and ensuring sustainability of
interventions. The project is now in its third phase with a renewed
focus on consultation and agreement with all the stakeholders on
improving HIV and TB laboratory services.
In April 2019, we launched a new patient safety program for
hospitals, called Preventing Risks of Infections and Medication
Errors in IV Therapy (PRIME) with Joint Commission International
(JCI) to address the two critical challenges in a hospital setting
- infection prevention and medication safety. PRIME is a Gold
Standard benchmarked safety program that will help enhance
patient and clinical outcomes by eliminating complications and
improving safety for patients and providers leading to accessing
better care.
countries including Europe, Middle East, Africa, South East
Asia, Korea, Japan, Australia and New Zealand. As science and
technology transform our markets, the creativity, innovation
and commitment of 300 people employed at Bawal remain
critical to our success in India.
Not only do our associates wake up to embrace the
opportunity to bring life-changing innovations to market, but
this also creates a new day for healthcare providers, researchers
and patients. As India expands its healthcare horizons, we
continue to bring our experience in infectious disease
diagnosis and infection control, immune system monitoring,
improving medication and supply management, bringing cost
efficiencies in procedural areas, helping clinicians reduce the
risk of infections and advancing patient care.
Advancing healthcare with skill building and
trusted partnerships
Our unwavering commitment to healthcare is not only driven
by company results but more so from our passion towards
helping those who deliver healthcare. From hospitals to
pharmacies, the nursing wards to operating theatres and
the 'patient's bedside’, BD's products and services penetrate
through many layers of healthcare. By improving medical
discovery, diagnostics, and the delivery of care, we at BD seek
to empower the service providers; be it researcher in the
Unwavering
Commitment to
Healthcare
E
very day is a new opportunity to make a difference in an evolving
world and advance the world of health. Over the last 120-plus years,
BD has been a critical supplier to the healthcare industry with a legacy
of innovation. From the first safety-engineered syringe to the first evacuated
blood collection tubes, the first commercial fluorescence-activated cell
sorting system, the first automated medication dispensing cabinet and the
first smart infusion pump, BD has been a leader in helping clinicians be more
efficient and cost effective while helping to improve patient and healthcare
worker safety.
With an overarching vision to improve patient outcomes in India, our journey
began in 1995 with the setting up of the world-class manufacturing plant
in Bawal, Haryana. Spread across 12.5 acres of land, the plant has a capacity
to churn out over a billion medical devices and also exports to over 50
This is evident in our approach to emerging
worldwide health concerns, such as
antimicrobial resistance (AMR), which
could possibly cause up to 10 million
deaths annually by 2050, surpassing deaths
currently caused by cancer.
Advancing the world of health:
Becton Dickinson India Pvt Ltd
BD has been a leader in helping clinicians be
more ef cient and cost effective while helping to
improve patient and healthcare worker safety.
Technological Breakthroughs
Developing the next generation of solutions for clinicians and
researchers is just the beginning of our industry leadership. As we
grow into one of the top five largest medical technology companies in
the world, we are also leading in areas that are critical to the future of
our industry and to society at-large. This is evident in our approach to
emerging worldwide health concerns, such as antimicrobial resistance
(AMR), which could possibly cause up to 10 million deaths annually by
2050, surpassing deaths currently caused by cancer.
We no longer focus on just new products, but instead we determine
how we can bring a suite of products and services to solve customer
challenges. We are redefining medication management technologies
to support hospitals and health systems to make their process safer,
smarter and simpler. BD continues to be on the front lines of helping
medical researchers develop a new generation of diagnostics and
therapies through our expertise in bioscience and genomics.
Many life-changing inventions are the result of scientific breakthroughs.
One such is BD Vacutainer® Tube. For Joseph Kleiner, a personal event
served as motivation to design a product that would revolutionize
bloodcollection.Hisideasparkedintothe“Evacutainer”bloodcollection
system that was patented in 1949 and later become known as the BD
Vacutainer® Tube. 2019 marks the 70th anniversary of the tube’s patent.
From supporting medical research, enhancing diagnosis of infectious
diseases and cancer, promoting infection prevention, equipping
surgicalandinterventionalprocedurestosupportingthemanagement
of life-threatening diseases, one thing remains constant— BD’s
unwavering commitment to doing what is right.
As we walk the long, arduous journey of quality healthcare, we are
inspired by our role in serving the caregivers, researchers and other
healthcare professionals who serve patients. At BD, we will continue
to drive forward and innovate because we know there is a patient at
the end of everything we do.

When we did a detailed business field analysis
of the healthcare scenario, with particular
focus on the needs in India, we realized
that the healthcare needs of our country
are diverse. Though healthcare in India is a
necessity, it still comes packaged as a luxury
to the vast majority. We are burdened by
a combination of infectious diseases and
lifestyle diseases in our country. Innovative
solutions, unconventional business models
and unorthodox care delivery systems
would be the key drivers of healthcare.
Indian healthcare is on the cusp of a digital
transformation. India’s digital connectivity is
poised to grow at an accelerated rate from 30
per cent in 2017 to 80 per cent in 2034, and is
driving the following trends:
a. Flipped care: Similar to most sectors
around the world, focus has shifted from
the provider to the patient. “Flipped
health care” puts control in the hands
of patients, with the goal of improving
health and care delivery while also
reducing the cost.
b. Digital Health: This is a real game
changer. It is just not the App on the
Bosch technology offerings could be put to use, to
improve the quality of people’s lives.
Bosch: Innovative
products and solutions
in the healthcare space
T
echnology and in particular, the Internet of Things (IoT) is fundamentally changing all
facets of life, from how we live, work and get around - homes are becoming smarter,
factories more productive, and mobility is taking on a fundamentally new form. True to
its tagline,“Invented for life”, Bosch is constantly developing innovative Connected Products, with
an intention to make all aspects of life easier. One such area, where Bosch is looking at to make a
fundamental impact on human life is healthcare.
Robert Bosch Engineering and Business Solutions (RBEI), headquartered in India, was
incorporated as a software development center of Bosch in the year 1997. With currently over
20,000 associates, RBEI is a strategic partner powering Bosch Business divisions worldwide.
RBEI healthcare believes that the future is in ‘Connected world’ inhabited by ‘Connected Life’
and aims to be a partner of choice to deliver IoT enabled innovative healthcare solutions for a
large scale, mass impact.“With a strong linking of our technology expertise in sensors, software
and services, RBEI healthcare is a preferred partner in the international marketplace and is
transforming the core nuggets of care delivery”says Guruprasad, VP Healthcare at RBEI.
mobile phone, but putting to use the computing power of
today’s smart phones for delivering Point of Care diagnosis and
last mile connectivity.
c. Front line innovations: Low-cost portable innovations to cater to
the needs of our vast rural population will help increase access by
providing Point of Care diagnostics, tele and remote consultations.
We strongly believe that device manufacturers must move beyond
product centric business models and use patient-oriented service
design (like a smart IoT enabled platform) to create comprehensive
healthcare experiences.
Bosch Healthcare leverages its precision engineering and state-of-
the-art technology in Internet of Things (IoT), sensor technology and
Social Mobility Analytics Cloud (SMAC), to promote innovation in a
patient-centric healthcare delivery model. This is exactly how we have
been enabling medical device companies to transform care delivery.
We see the following three pivots that would be
major tenets for this change in the medical field:
1. People: With increasing consumerism, patients are at the driver’s
seat, and will be in the center of the entire healthcare ecosystem.
2. Data: Data will be one of the strongest buzzwords in the
years to come. Electronic Health Records (EHRs) will become
Comprehensive Health Records (CHRs) to accommodate data
from many sources including remote health care data and social
determinants of healthcare.
3. Technology: Emerging technologies like AI, cognitive, machine
learning will unlock the value of data, and open source
technologies like block chain (distributed ledger technology), will
help to address the challenges related to security and privacy.
The last point – ‘technology’ is at the heart of change right now.
With the advancement of technology there is a conscious demand
for better engagement and quality services in the healthcare sector.
Customers anticipate intuitive, smart interactions as opposed to the
traditional models of care delivery. Care delivery is also undergoing
changes with the primary focus being on providing value-based
services. With the help of emerging technologies, there is an
increasing shift from traditional to ‘smart’.
In India especially, technology can play a key enabler in improving the
healthcare scenario in the rural sector. We are already working on rural
healthcare delivery solutions to address the critical needs of the same.
I would like to highlight a few of the most pressing
issues we are dealing with:
Lack of trained medical professionals at Point of Care
Lack of early diagnosis that helps avoid medical complications
Affordable and accessible healthcare that does not impact the
daily livelihood
With technology advancements, we can also continuously monitor
and flag critical alerts, and thus ensure pro-active, quality care is
provided at the right time, thereby reducing the pressure on the
current clinical set-up. A connected health ecosystem with the
key tenets of smart, personalized, portable and virtual, can aid the
improvement in focus on preventive, diagnostics and wellness, and
reduce the load on therapeutic in the entire spectrum of care.
All appropriate investments in terms of innovation funding,
partnerships with external associations like NATHEALTH, global
research universities and other ecosystem partners, are being made.
Intellectual property in the form of Patents, as well as various thought
leadership publications like White Papers and Blogs have been
continuously generated. We have won many laurels like the Edison
award, HIMSS Asia pacific award to name a few.
We can use technology as a key enabler to promote better health, lower
costs and ensure last mile connectivity. Bosch technology is designed to
fascinate, as well as to improve quality of life. Bosch believes that we can
make a difference to the field of Healthcare in India.
With input from Mr Guruprasad, VP,
Healthcare domain, Robert Bosch
Engineering and Business Solutions.

technologies are unable to treat genetic,
debilitating lifestyle, age-related, auto-
immune disorders, cancers etc.; that
afflict the society. Dr. Mahajan brings new
dimensions in the management of diseases
from ‘Pills to Cells.’ He believes that cell-
based therapy holds immense potential
in treatment of several chronic and life-
threatening diseases. Dr. Mahajan’s vision
is to replace organ transplantation with
his concept of autologous cell transplant
using the body as a bioreactor. He aims to
address the challenges currently associated
with organ transplantation namely limited
donors/source of organs and graft vs.
host disease, by capitalizing on the varied
properties of cells and growth factors in our
body.
Dr. Mahajan has collaborated academically
at national and international levels with
universities in Maharashtra (MUHS), Ohio
(Ohio State University) and Indianapolis
(Indiana University) for clinical trials. He
has been honored with many international
awards. He has also published a patent
for treatment of Avascular Necrosis using
Regenerative Medicine approach and
National patents for Avascular Necrosis,
Ankylosing Spondylitis, Ischemic-tolerance
Mesenchymal Stem Cell treatment,
Technology for isolation of dental pulp stem
cells. He has many research publications to
his credit and has ongoing clinical trials
exploring new technologies like Tissue
Nano Transfection, Cancer Immunotherapy
(NK Cells), PRP lysate and many more.
MAVERICK APPROACH:
In 2011, Dr. Mahajan decided to take a
leap in the field of regenerative medicine
and established his brainchild StemRx
BioScience Solutions Pvt. Ltd. a top-notch
cGMP grade facility. StemRx is the first of
its’ kind in Asia for immunotherapy using
Prodigy system. StemRx today has emerged
as a leader in clinical quality and innovation
in the healthcare industry, redefining the
progression of medical science. StemRx
has devised treatment protocols for 6500+
patients till date. StemRx works with the
aim of simplifying research in addition to
ensuring cost effectiveness and breaking
the barriers of conventional treatments.
LEGEND OF
LIVING DRUG
Dr. Mahajan brings new dimensions in the management of
diseases from ‘Pills to Cells.’ He believes that cell-based
therapy holds immense potential in treatment of several
chronic and life-threatening diseases.
R
apid progress in technology and better understanding of human biology has led to
the emergence of innovations to unmet needs and failing conventional medicine.
The present century is witnessing breakthrough developments, with Regenerative
Medicine (RM) being at the forefront.This field focuses on the replacement and regeneration
of tissues or organs by utilizing the potential of endogenous repair mechanisms of the
body. Moving beyond the scope of conventional medicine, RM is the intersection of
various technological approaches including gene therapy, cell-based therapy, and tissue
engineering and others.
A FORMIDABLE INTELLECTUAL:
Counted as one among the leading regenerative medicine experts in India, Dr. Pradeep V.
Mahajan is an internationally acclaimed general surgeon, urologist as well as an academician
and regenerative medicine researcher by profession for over three decades.
He believes in what Albert Einstein said, “We cannot solve the problem by using the same
kind of thinking we used when we created them.”, when it comes to challenges in current
medical systems and treatments.
Dr. Mahajan is of the opinion that science is dynamic, and one must continuously
strive to find solutions to address unsolved problems. He feels that the conventional
Dr. Pradeep Mahajan believes in “Repair without cuts” by offering
non-invasive therapies and viable options for 80+ life threatening
conditions. A vision turned reality of innovations in the dynamics
of medicine is propelling him to become a part of the medical
revolution of the 21st century that is setting new standards every
day in cell-based research and regenerative medicine.
StemRx BioScience Solutions Pvt. Ltd. envisions to create a patient-
centric tertiary healthcare experience focusing on non-intrusive
quality care by utilizing cutting edge technologies of regenerative
medicine. With patients coming from all around the globe, StemRx
is focused on providing a delightful and ecstatic experience to the
patients. His never-ending passion and the dedicated effort has
helped StemRx in achieving milestones since 2011.
AWE-INSPIRING OBJECTIVE:
Dr. Pradeep Mahajan aims to promote cell-based therapy at a global
level, while also ensuring that the technology is accessible to the
masses. When asked about his ideology behind StemRx, he said, “You
carry your own repairing kits within yourself’. Soon, I believe that
there will be a day when treatments will comprise of Cells and not
Pills!” Dr. Mahajan not only believes in offering medical assistance to
those in need but also likes to share his knowledge pearls with the
young generation of the country. He firmly believes that if harnessed,
regenerative medicine is the living drug molecule that could
revolutionize the world of healthcare.
CURE FOR TOMORROW:
Visualizing the changing dynamics of medicine, Dr Pradeep V
Mahajan believes that when you look back at the 20th century, the
greatest scientific achievements which can change human life will
not be from the field of space science or computer science but will
be from regenerative medicine. Dr. Mahajan strives towards finding
scientific breakthrough technologies that was never imagined.
The ongoing discovery of cell-based therapy has given rise to a
new alternative treatment protocol. Regenerative medicine has
shifted our clinical goal from repair to regeneration. Regenerative
medicine is truly revolutionizing the field of medicine through
autologous therapy using cells and growth factors to address the
root cause of the disease. With this goal, the concept has expanded
to a variety of other applications such as Tissue engineering and
Genetic medicine. Future goals should be towards use of stem cell
rich blood from the umbilical cord as a key element in achieving
regeneration. These clinical goals can provide long-term cures to
previously untreatable injuries and diseases.
We cannot solve the problem by using
the same kind of thinking we used
when we created them.
INNOVATIVE HEADWAYS:
Regenerative Medicine is breaking the
barriers for treatment of diseases for a
variety of reasons- it leads to repopulation
of healthy cell pools, regenerates tissues,
boosts immunity, rejuvenates organs, and
improves the quality of life. Regenerative
Medicine exclusively supports all avenues
that lead to the replacement or regeneration
of human cells, tissue or organs, to restore
or establish normal function. The sector is
rapidly evolving and multidisciplinary in
nature. The field of regenerative medicine is
promising and can be explored to augment
organ function, repair, and even regenerate
by utilizing the body’s own repair and healing
mechanisms. One may say that the
body is converted into a natural
reactor to heal itself.
Dr. P. V. Mahajan
Urosurgeon and Regenerative Medicine Researcher

28 FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE FORBES INDIA MARQUEE . LEADERS IN HEALTHCARE 2928 FORBES INDIA MARQUEE . LEADERS
Care24 was started in 2014 by IIT Kanpur alumni Vipin Pathak and
Garima Tripathi. Starting as a personal need to get better care for
their own parents, the team decided to start reliable medical services
at home in Mumbai and expand to other cities. The need for a nurse
for simple blood pressure check or injections is difficult for children
who either have to take off from work to visit hospitals or rely on
local agencies. The local agencies have no reliability or quality check
on services. Care24 started solving this basic need of a qualified
medical professional who could provide standard services at home.
Research has proven that patients can recover faster (20-30%) due
to higher comfort at home and reduce hospital readmission by 27%.
Background verification, medical and soft skill training and a very
strong technology foundation has helped us deliver quality care at
home. We have been able to significantly increase care providers
income with more work and higher salaries.
ThehomecaresegmentishighlyfragmentedinIndiaunlikeUS,Japan
and others where the government or insurance cover has made it is
an organized and regulated industry. World home healthcare market
is expected to reach $349.8 billion by 2020 from $227.5 billion in
2015 growing 9% annually. In India the market size is roughly $4
billion with ancillary markets about $20 billion. With increasing
nuclear families and growing elderly population in metros, there is a
huge gap between the demand and available solutions.
We are determined to bring quality and standardization in this
sector. Care24 now serves 1200 patients every day. Today, we have
over 2000 active medical caregivers and the company has helped
over 50,000 families recuperate in the comfort of their homes.
The quality of delivered services has made us the trusted brand for
home healthcare both for the customers and caregivers. We take
pride in the fact that more than 70% of our caregivers are hired
through referral program showing high levels of trust placed in us
by our caregivers. Similarly 50% of our customer come from referral
from families we have served in past. The biggest challenge that a
customer faces today is lack of reliable care partner when they need
the most. We ensure guaranteed service and faster resolution using
technology and trained staff.
Through our technology and supervision every patient service and
recovery is monitored from timely start, feedback, recovery, query
resolution from the consumer, patients and caregivers.
We have achieved this trust by investing in upskilling the caregiver
and through effective use of technology. Customer and caregiver
have mobile application to keep track of the services.
Every caregiver also gets a bank account and this has brought
financial inclusion to more than 5000 providers who were left out of
the digital economy.
The inhouse technology makes the unit economics profitable and
Care24 is the only homecare company in India that will be profitable
Care24: Reliable
Care at Home
C
are24 is one of the leading home healthcare company and
envisions to become the biggest platform for all health
services at home. Strongly built on technology and heavily
invested in quality and training processes, we make home-healthcare
reliable, accessible and affordable for one and all. Our services are
currently available in Mumbai and NCR region. We aim to start
the services in 5 more cities this year. We offer patient services to
multiple acute and chronic conditions cases of Post-Hospitalization,
Stroke, Cardiac, Neuro, Ortho, Elderly bedridden, Dementia, Cancer
etc. The core services offered are Medical Nursing, Physiotherapy,
Attendants, ICU & Step down at Home.
soon. The processes and systems developed are poised to take 10
more cities without adding a lot of overheads and hence providing
affordable care to more families.
Care24 is looking to expand its services to five more
cities in the next 12 months.
The prospective cities are Bengaluru, Chennai, Hyderabad, Kolkata
and Pune. The elderly population is expected to grow to 325 million
from current 100 million. The need for condition management
for chronic diseases, cardiovascular and cancer is exponentially
increasing and the in-home healthcare for the aged is becoming
a necessity. Insurance, Hospitals, Pharma and other healthcare
players are keen to partner with Homecare companies to reduce
LOS (length of stay) in hospital, increase hospital capacity to service
critical patients and improve overall health of patients.
Care24 is also looking at specific areas such as specialised medical
delivery, providing complete care, diagnostic and medical
equipment services. We aim to serve 3000 patients per day from
the current 1,200 per day over the 12 months.
The biggest challenge in homecare is the lack of
trained staff.
The company plans to train 10000 healthcare professionals for
elderly care and specialised treatments such as cancer care and
neurological care in association with specialised agencies such as
NSDC, AIIMS and Tata Memorial, among others. We believe that
skilling and training is the only way forward for creating the right
kind of talent pool for the healthcare industry. With the use of our
large network, we aim to lead in this market by creating technology
and supply pool that can serve the industry in the coming decade.
Care24 platform has helped attendants and nurses build their own
homes, pay for their kids education and get treatment for their loved
ones. The 360 degree approach in taking care of our caregivers has
enabled us to provide the best care to the patients.
Healthcare is about long term investments and consistent efforts.
Our continuous effort in working with customer’s requirements,
creating new service lines and empowering supply financially and
technologically has helped us to become theTrusted brand in Home
care. With the addition of new cities, disease specific offerings and
more affordable products and services across different verticals, our
long term goal is to serve 50,000 patients/day on the platform for all
of their healthcare needs.
Garima Tripathi, Co-Founder & COO
Vipin Pathak, Co Founder & CEO
Care24 is solving the basic medical need
for quali ed medical professional providing
standardized services at home.
The prospective cities
are Bengaluru, Chennai,
Hyderabad, Kolkata
and Pune. The elderly
population is expected
to grow to 325 million
from current 100 million.
The need for condition
management for chronic
diseases, cardiovascular
and cancer is exponentially
increasing and the in-home
healthcare for the aged is
becoming a necessity.

Forbesindia - Dr. Alok Sharma

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Forbesindia - Dr. Alok Sharma

Similar to Forbesindia - Dr. Alok Sharma (20)

Recently uploaded

Recently uploaded (20)

Forbesindia - Dr. Alok Sharma